OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. It focuses on the provision of consulting services and the development of a cannabis soluble tablet delivery system. The company was founded on March 7, 2008 and is headquartered in Ramat Gan, Israel.
Company profile
Ticker
OWCP
Exchange
Website
CEO
Mordechai Bignitz
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DYNAMIC APPLICATIONS CORP
SEC CIK
Corporate docs
IRS number
980573566
OWCP stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
25 Aug 21
8-K
Changes in Control of Registrant
5 Mar 21
8-K
Other Events
14 Dec 20
8-K/A
Departure of Directors or Certain Officers
3 Nov 20
8-K
Submission of Matters to a Vote of Security Holders
25 Sep 20
8-K
Submission of Matters to a Vote of Security Holders
16 Sep 20
DEFA14A
Additional proxy soliciting materials
4 Sep 20
8-K
Submission of Matters to a Vote of Security Holders
2 Sep 20
DEF 14A
Definitive proxy
14 Aug 20
PRER14A
Preliminary revised proxy
27 Jul 20
Latest ownership filings
SC 13G
Discover Growth Fund, LLC
21 Jun 21
SC 13D/A
Discover Growth Fund, LLC
21 Jun 21
SC 13D/A
Discover Growth Fund, LLC
30 Mar 21
SC 13D/A
Discover Growth Fund
5 Mar 21
SC 13D
Discover Growth Fund, LLC
25 Feb 21
3
Initial statement of insider ownership
11 May 20
3
YEHUDA BARUCH
28 Jun 17
5
Shmuel De-Saban
22 Jun 17
5
Mordechai Bignitz
22 Jun 17
3
Mordechai Bignitz
21 Jun 17
Institutional ownership, Q3 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.00 k |
Total shares | 4.50 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
IFP Advisors | 4.50 k | $1.00 k |